Rosetta Genomics' integrative research platform combining bioinformatics and state-of-the art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Rosetta develops and commercializes a range of proprietary microRNA-based tests, including RosettaGX Reveal (Thyroid microRNA Classifier) and RosettaGX Cancer Origin, as well as other molecular diagnostic assays. The company also offers core FISH, IHC and PCR-based testing capabilities and partnerships in pathology, endocrinology, oncology and urology. Rosetta’s cancer testing services are commercially available through its Philadelphia, PA- and Lake Forest, CA-based CAP-accredited, CLIA-certified labs. To Learn More, Visit: www.rosettagx.com
Looking for a particular Rosetta Genomics employee's phone or email?
The Rosetta Genomics annual revenue was $9 million in 2026.
4 people are employed at Rosetta Genomics.
Rosetta Genomics is based in Rehovot, Ta.
The NAICS codes for Rosetta Genomics are [62, 62151, 6215, 621].
The SIC codes for Rosetta Genomics are [80, 807].